Gastrointestinal disease
Conditions
Interventions
Group 1:Ciprofol intravenous injection
Sponsors
Gansu Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-65 years; ASA score is I or II; 2. Patients who plan to undergo painless digestive endoscopy; 3. SPO2>=92% when breathing air before surgery; 180mmg>=SBP>=90mmHg; 100>=DBP>=50mmHg; 4. 18kg/m^2<=BMI<=28kg/m^2; 5. Before the trial, understand the nature, significance, possible benefits, possible inconveniences and potential dangers of the trial in detail, understand the research procedures and voluntarily sign the informed consent in writing.
Exclusion criteria
Exclusion criteria: 1. Requires complex endoscopic diagnosis and treatment techniques; 2. Patients who are judged to be difficult to manage the respiratory tract (modified Markov classification IV); 3. Those who are allergic to or have contraindications to benzodiazepines, opioids, propofol, and propofol emulsion injection excipients; 4. Participated in clinical trials of other drugs as subjects within the past 3 months; 5. Those who cannot obtain informed consent, or those who are considered unsuitable by the investigator to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of intraoperative adverse events;Anesthesia recovery time; | — |
Countries
China
Contacts
Public ContactYan Wenjun
Outcome results
None listed